"They shouldn't be the Bank of Pfizer, holding all that cash, for God's sake," says Seamus Fernandez, an analyst for health-care investment bank Leerink Swann & Co. "Acquiring a company would give them access to a larger pipeline of products, and it would allow them to wring out more efficiency."
BusinessWeek
No comments:
Post a Comment